Guide | 13 December, 2018 | Download PDF
Medicines are an essential element in improving our health and well-being, and affordability is critical to making universal health coverage a reality. In the European Union EU, sky-rocketing prices of new, patented medicines are straining public health budgets and jeopardising access.
Our new brochure for policymakers and lawmakers in Europe focuses on the use of intellectual property management tools to improve access to safe, effective and quality-assured medicines.
The legitimate use of these tools to achieve public health goals should not be considered exceptional or limited to a specific geographical area or disease, but widespread and growing given that low-, middle, and high-income countries, alike, face increasing economic burdens linked to the procurement of pharmaceuticals. There is also growing pressure from patient groups and other stakeholders to make use of instruments, such as compulsory licences.